Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition

Blood. 2011 Jan 6;117(1):98-107. doi: 10.1182/blood-2010-03-273656. Epub 2010 Oct 8.

Abstract

To determine the influence of KIR and HLA class I polymorphism on human NK cell repertoires, 32 different clonotypes representing all possible combinations of 4 inhibitory KIR and NKG2A were analyzed by multicolor flow cytometry. In donors homozygous for the common group A KIR haplotype, a significant influence of HLA-C ligands was seen: KIR repertoires were dominated by clonotypes expressing a single KIR for the respective cognate ligand, either the C1-specific KIR2DL3 or C2-specific KIR2DL1. In contrast, in donors possessing the polymorphic group B haplotypes, a similar adaptation to cognate HLA-C was lacking. We suggest that this discrepancy is largely the result of a suppressive effect of the group B-specific KIR2DL2 on the frequency of KIR2DL1(+) NK cells. In functional assays, KIR2DL2 not only recognized C1 but also C2 ligands, showing overlapping specificity with KIR2DL1. Moreover, using an NK cell differentiation assay we show sequential acquisition of KIR2DL2 before KIR2DL1 on developing NK cells. Together, these observations are compatible with a ligand-instructed model of NK cell education, in which recognition of HLA class I by an inhibitory receptor (KIR2DL2) suppresses subsequent expression of a second receptor (KIR2DL1) of related specificity. Importantly, the ligand-instructed model fits to the observed KIR repertoires in both broad KIR haplotype groups.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Flow Cytometry
  • HLA-C Antigens / genetics
  • HLA-C Antigens / metabolism*
  • Haplotypes / genetics*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism*
  • Lymphocyte Activation
  • Models, Molecular*
  • Polymorphism, Genetic / genetics
  • Receptors, KIR2DL1 / genetics
  • Receptors, KIR2DL1 / immunology
  • Receptors, KIR2DL1 / metabolism*
  • Receptors, KIR2DL2 / genetics
  • Receptors, KIR2DL2 / immunology
  • Receptors, KIR2DL2 / metabolism*
  • Tissue Donors*

Substances

  • HLA-C Antigens
  • Receptors, KIR2DL1
  • Receptors, KIR2DL2